Journal
EXPERT OPINION ON PHARMACOTHERAPY
Volume 7, Issue 12, Pages 1591-1602Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1517/14656566.7.12.1591
Keywords
clinical management; Crohn's disease; genetics; pharmacogenomics; phenotypes
Categories
Ask authors/readers for more resources
Genetic research in inflammatory bowel disease, especially in Crohn's disease, has made significant progress during recent years. There have been > 10 total genome scans that have been performed, and susceptibility loci on several chromosomes have been identified. Together with candidate gene studies, these scans have led to the identification of several susceptibility genes, with CARD15 being the most important. These genetic data have already provided important insights into the pathophysiology of inflammatory bowel disease and are stimulating future research. On the other hand, genotype-phenotype associations have illustrated the heterogenic nature of the disease. Although the clinical application of this knowledge is so far limited, there is significant optimism that an individual management of patients based on genetic data will be possible in the near future.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available